ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf LifeExtends...

Related Keywords

United States ,Florida ,Boca Raton ,Michelle Pappanastos ,Adam Grossman ,Drug Administration ,Biologics Inc ,Business Development Corporate Strategy ,Nasdaq ,Product Administration To Patients ,Exchange Commission ,Room Temperature ,Storage Conditions ,Any Point During ,Month Approved Shelf ,Prior Room Temperature Storage Allowance ,Improved Inventory Management ,Product Administration ,Extended Ambient Storage Conditions ,Immediately Effective ,Now Commercially Available ,United States Food ,Biologics License Applications ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Business Development ,Corporate Strategy ,Managing Director ,Argot Partners ,